Get started
Author

K. Martin Kortüm

Observed names: K. Martin Kortum, Kortüm, K. Martin
ORCID: 0000-0002-7011-0286
Observed ORCID: 0000-0002-7011-0286
OpenAlex ID: A5133394807
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma
2026 · Holly Lee, Sungwoo Ahn, et al. · Nature Medicine · 12
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial
2026 · Marc S. Raab, Niels Weinhold, et al. · Nature Medicine · 7
PDF
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptors
2026 · Patrick Eiring, Maximilian J. Steinhardt, et al. · Science Advances · 3
PDF
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial
2026 · Marc S. Raab, Niels Weinhold, et al. · Nature Medicine
PDF
Determinants of Long‐Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis
2026 · Maximilian J. Steinhardt, Ute Hegenbart, et al. · American Journal of Hematology
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma
2026 · Han, Seungbin, Haertle, Larissa, et al. · Figshare
Additional file 2 of Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma
2026 · Han, Seungbin, Haertle, Larissa, et al. · Figshare
Additional file 1 of Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma
2026 · Han, Seungbin, Haertle, Larissa, et al. · Figshare
Additional file 3 of Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma
2026 · Han, Seungbin, Haertle, Larissa, et al. · Figshare
Works count: 10
Citation count: 23
H-index: 3
I10-index: 1
Year
Topic
Type